QSS
BLCM

Quantitative Systematic Strategies’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Quantitative Systematic Strategies’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,457
Closed -$299K – 833
2015
Q4 		$299K Buy
+1,457
New +$261K 0.08% 787
2015
Q1 		– Sell
-1,397
Closed -$323K – 508
2014
Q4 		$323K Buy
+1,397
New +$300K 0.13% 217

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantitative Systematic Strategies's BLCM Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2016, closing a stake of 1,457 shares — an estimated $299K sold.

Quantitative Systematic Strategies first reported a position in BLCM in Q4 2014 and held it in 2 quarters. The position peaked at $323K in Q4 2014. 78 funds tracked by Wall St. Rank hold BLCM as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,457 Bellicum Pharmaceuticals, Inc. shares in Q1 2016, an estimated $299K.
  • Quantitative Systematic Strategies first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Bellicum Pharmaceuticals, Inc. position peaked at $323K in Q4 2014.
  • 78 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.